Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nora Therapeutics, Inc.

Request full access

Therapeutics for IVF failure and recurrent pregnancy loss

Palo Alto, United StatesFounded 2007Biotech & Life Sciences

About Nora Therapeutics, Inc.

Nora Therapeutics was a biopharmaceutical company focused on developing treatments for unmet needs in reproductive medicine, specifically addressing in vitro fertilization (IVF) failure and recurrent pregnancy loss. The company was founded in 2007 by Chris McClain and was headquartered in Palo Alto, California.

The company's lead product candidate was NT100, a biologic agent designed to be similar to a naturally occurring protein in the female reproductive tract. The goal of NT100 was to improve the chances of embryo implantation and maintain pregnancy by optimizing maternal-fetal immune tolerance. Nora Therapeutics conducted Phase 2 clinical trials for NT100, including the THRIVE-IVF trial for women with a history of failed IVF cycles and the RESPONSE trial for women with unexplained recurrent pregnancy loss. The company's business model was centered on the research and development of these specialized therapeutics with the aim of bringing an FDA-approved treatment to a market with few options.

Nora Therapeutics was venture-backed, raising a total of $37.8 million over five funding rounds from investors including Novo Holdings, Vivo Capital, Prospect Venture Partners, Rho Ventures, and Burrill & Company. A significant Series B financing round in April 2014 raised $18 million to advance the clinical trials for NT100. Despite its efforts in clinical development and securing funding, Nora Therapeutics ultimately went out of business, with its status listed as closed around January 2017.

Source: Dealroom company data

At a glance

Status
Closed
Employees
2
Open positions
None listed
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Fertility, Pregnancy, Biotechnology, Drug Development, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC May 2015 — — Undisclosed —
SERIES B✓Equity / VC Apr 2014 $18M $72M Rho Ventures · Burrill · Prospect Venture Partners · Novo Holdings —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Nora Therapeutics, Inc. website traffic

Latest recorded traffic for Nora Therapeutics, Inc. is 0 monthly website visits. Nora Therapeutics, Inc.'s team declined 33.3% over the past year.

Latest monthly visits0 1-year team growth-33.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nora Therapeutics, Inc. in the Palo Alto ecosystem

Live from Dealroom

The Nora Therapeutics, Inc. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Novo Seeds
  • Rho Ventures
  • Burrill
  • Prospect Venture Partners
  • Novo Holdings
  • Vivo Capital

Other known investors1 additional known investor

  • Rho Canada Ventures
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Palo Alto HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nora Therapeutics, Inc. on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nora Therapeutics, Inc.’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.